Respiratory Inhalers

Respiratory Inhalers

Global Respiratory Inhalers Market to Reach $51 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Respiratory Inhalers estimated at US$33.9 Billion in the year 2020, is projected to reach a revised size of US$51 Billion by 2027, growing at aCAGR of 6% over the period 2020-2027. Manual, one of the segments analyzed in the report, is projected to record 5.4% CAGR and reach US$45.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Digital segment is readjusted to a revised 13.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $12.2 Billion, While China is Forecast to Grow at 8.2% CAGR
The Respiratory Inhalers market in the U.S. is estimated at US$12.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$7 Billion by the year 2027 trailing a CAGR of 8.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.1% and 5.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Select Competitors (Total 131 Featured) -

  • Adherium Limited
  • AstraZeneca plc
  • Beximco Pharmaceuticals Ltd.
  • Boehringer Ingelheim International GmbH
  • CHIESI Farmaceutici S.p.A.
  • Cipla Inc.
  • GlaxoSmithKline plc
  • Glenmark Pharmaceuticals Ltd.
  • HELTMAN Medikal A.S.
  • Koninklijke Philips N.V.
  • Merck & Co., Inc.
  • Mundipharma International Limited
  • Novartis International AG
  • Omron Healthcare, Inc.
  • PARI GmbH
  • Teva Pharmaceutical Industries Ltd.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
World Economic Growth Projections (Real GDP, Annual % Change) for 2019 to 2022
Inhalation Technology for Tackling COVID-19s
Iconovo Joins Hands with ISR to Develop Inhaled Vaccine for COVID-19
Ongoing Studies ExploreUse of Inhalers-based Therapies to Treat COVID-19
Inhalers Lead to Marked Reduction in Onset of Severe Symptoms for Early COVID-19 Patients
Researchers Bet on Corticosteroid Inhalers to Treat COVID-19 Patients
Use of Inhalers amid COVID-19 Medical Crisis Outweigh Risks for Asthma Patients
COVID-19 Pandemic Pushes Patient Compliance Linked with Inhaler-based Drug Regime
Stockpiling Under COVID-19 Shadow Exacerbates Steroid Inhaler Supply Concerns
Concerns over COVID-19 Virus Transmission through Nebulizers Paves Way for Broader Acceptance of Respiratory Inhalers
Respiratory Inhalers – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Respiratory Inhalers: A Prelude
Types of Respiratory Inhalers
Metered-dose inhaler
Dry Powder Inhaler (DPI)
Soft Mist Inhalers (SMI)
Nebulizers
Pulmonary Drug Delivery using Inhalers Hold Critical Significance to Provide Respite to Patients
High Prevalence of Respiratory Diseases to Drive Growth
Prevalence Percentage of COPD, Asthma, and Allergic Rhinitis for Select Countries: 2016
EXHIBIT 2:Chronic Disease Management in Developed Countries (2019): Percentage Distribution of Patient Population by Chronic Disease Type in the US, Germany, and UK
Sustained Emphasis on Bringing Novel Pulmonary Disease Treatments Augurs Well for Market Growth
Dry Powder Inhalers Set to Drive Gains
Digital Dose Inhalers Accelerate Growth Pace
Global Cost of Respiratory Therapy by Disease (2019): Percentage Breakdown of Therapy Costs for Asthma, Chronic Obstructive Pulmonary Disease (COPD), Idiopathic Pulmonary Fibrosis, and Others
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
Growing Homecare Market Drives Demand for Respiratory Diagnostic and Therapy Devices
3. MARKET TRENDS & DRIVERS
Rise in Incidence of Asthma Drives Growth Prospects
Role of Respiratory Inhalers in Asthma
Asthma Rescue Inhalers Medications
Asthma Long-Term Medications
Select Asthma Stats
Asthma Prevalence in the US by Age: 2019
Asthma Prevalence in the US by Gender: 2019
Asthma Prevalence in the US by Race/Ethnicity: 2019
Rising Prevalence of Asthma in Children Supports Growth
Mounting Incidence of COPD Drives Use of Inhalers
COPD Stats
Global Prevalence of COPD by Age Group: Percentage of Men and Women Affected by the Condition
Reported COPD Cases in the US in Million : 2014-2018
Acute Respiratory Distress Syndrome: An Emerging Space for Inhalers
ARDS Fact Sheet
Rising Incidence of Cystic Fibrosis Offers Market Potential
Global Frequency of Genetic Mutations Carrying Cystic Fibrosis
Cystic Fibrosis Fact Sheet
Combination Therapies Gain Interest as Effective Treatment for Considered Influence Respiratory Inhaler Demand
Nebulizer Innovations Drive Opportunities
Global Nebulizer Devices Market by Type: 2020
Manufacturers Venture into Nebulizers Designed to Fight COVID-19
New Hot Melt Extrusion Method to Enhance Inhaler Technology
Advances in Pulmonary Drug Delivery Devices Drive Adoption
Select Innovations & Advancements
Smart Inhalers Gain Traction
Artificial Intelligence to Add Sophistication to Inhaler Technology
3D Printing Seeks Role in Inhaler Manufacturing
Rise in Air Pollution Levels and Consequent Increase in Respiratory Diseases Trigger the Demand for Inhalers
Global Indoor Air Pollution Related Fatalities by Health Condition (In %) for 2020E
Air Pollution Levels Worldwide: Average PM2.5 Concentration (in µg/m³) in Select Countries for 2019
Global Carbon Dioxide (CO2) Emissions (in Billion Metric Tons): 2010-2019
Countries with Highest Carbon Emissions Worldwide: Percentage Breakdown of Carbon Emissions by Country (in %) for 2020E
Inhalers and Pollution: The Irony
Ballooning Geriatric Population to Spur Demand
Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
TABLE 5: Global Life Expectancy at Age 60 and 80 Years: 2010-2015; 2020-2025; and 2045-2050
Increase in Healthcare Spending Stirs Demand
World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Manual by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Manual by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Manual by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 4: World Recent Past, Current & Future Analysis for Digital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Digital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Digital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 7: World Recent Past, Current & Future Analysis for Metered Dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Metered Dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Metered Dose by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 10: World Recent Past, Current & Future Analysis for Dry Powder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Dry Powder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Dry Powder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 13: World Recent Past, Current & Future Analysis for Nebulizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for Nebulizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for Nebulizers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 16: World Recent Past, Current & Future Analysis for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for Asthma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 19: World Recent Past, Current & Future Analysis for COPD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for COPD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 21: World 15-Year Perspective for COPD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 22: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 23: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 24: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 25: World Recent Past, Current & Future Analysis for Respiratory Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 26: World Historic Review for Respiratory Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 27: World 15-Year Perspective for Respiratory Inhalers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
Respiratory Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
TABLE 28: USA Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 29: USA Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 30: USA 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 31: USA Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 32: USA Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 33: USA 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 34: USA Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 35: USA Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 36: USA 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
CANADA
TABLE 37: Canada Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 38: Canada Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 39: Canada 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 40: Canada Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 41: Canada Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 42: Canada 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 43: Canada Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 44: Canada Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 45: Canada 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
JAPAN
Respiratory Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
TABLE 46: Japan Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 47: Japan Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 48: Japan 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 49: Japan Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 50: Japan Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 51: Japan 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 52: Japan Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 53: Japan Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 54: Japan 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
CHINA
Respiratory Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
TABLE 55: China Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 56: China Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 57: China 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 58: China Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 59: China Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 60: China 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 61: China Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 62: China Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 63: China 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
EUROPE
Respiratory Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
TABLE 64: Europe Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 65: Europe Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 66: Europe 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 67: Europe Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 68: Europe Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 69: Europe 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 70: Europe Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 71: Europe Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 72: Europe 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
TABLE 73: Europe Recent Past, Current & Future Analysis for Respiratory Inhalers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 74: Europe Historic Review for Respiratory Inhalers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 75: Europe 15-Year Perspective for Respiratory Inhalers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
FRANCE
Respiratory Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
TABLE 76: France Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 77: France Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 78: France 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 79: France Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 80: France Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 81: France 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 82: France Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 83: France Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 84: France 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
GERMANY
Respiratory Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
TABLE 85: Germany Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 86: Germany Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 87: Germany 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 88: Germany Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 89: Germany Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 90: Germany 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 91: Germany Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 92: Germany Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 93: Germany 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
ITALY
TABLE 94: Italy Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 95: Italy Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 96: Italy 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 97: Italy Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 98: Italy Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 99: Italy 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 100: Italy Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 101: Italy Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 102: Italy 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
UNITED KINGDOM
Respiratory Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
TABLE 103: UK Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 104: UK Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 105: UK 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 106: UK Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 107: UK Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 108: UK 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 109: UK Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 110: UK Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 111: UK 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
SPAIN
TABLE 112: Spain Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 113: Spain Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 114: Spain 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 115: Spain Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 116: Spain Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 117: Spain 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 118: Spain Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 119: Spain Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 120: Spain 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
RUSSIA
TABLE 121: Russia Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 122: Russia Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 123: Russia 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 124: Russia Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 125: Russia Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 126: Russia 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 127: Russia Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 128: Russia Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 129: Russia 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
REST OF EUROPE
TABLE 130: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 131: Rest of Europe Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 132: Rest of Europe 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 133: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 134: Rest of Europe Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 135: Rest of Europe 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 136: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 137: Rest of Europe Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 138: Rest of Europe 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Respiratory Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
TABLE 139: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 140: Asia-Pacific Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 141: Asia-Pacific 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 142: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 143: Asia-Pacific Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 144: Asia-Pacific 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 145: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 146: Asia-Pacific Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 147: Asia-Pacific 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
TABLE 148: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Inhalers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 149: Asia-Pacific Historic Review for Respiratory Inhalers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 150: Asia-Pacific 15-Year Perspective for Respiratory Inhalers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
AUSTRALIA
Respiratory Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
TABLE 151: Australia Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 152: Australia Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 153: Australia 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 154: Australia Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 155: Australia Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 156: Australia 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 157: Australia Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 158: Australia Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 159: Australia 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
INDIA
Respiratory Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
TABLE 160: India Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 161: India Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 162: India 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 163: India Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 164: India Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 165: India 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 166: India Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 167: India Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 168: India 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
SOUTH KOREA
TABLE 169: South Korea Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 170: South Korea Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 171: South Korea 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 172: South Korea Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 173: South Korea Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 174: South Korea 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 175: South Korea Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 176: South Korea Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 177: South Korea 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
REST OF ASIA-PACIFIC
TABLE 178: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 179: Rest of Asia-Pacific Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 180: Rest of Asia-Pacific 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 181: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 182: Rest of Asia-Pacific Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 183: Rest of Asia-Pacific 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 184: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 185: Rest of Asia-Pacific Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 186: Rest of Asia-Pacific 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
LATIN AMERICA
Respiratory Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
TABLE 187: Latin America Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 188: Latin America Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 189: Latin America 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 190: Latin America Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 191: Latin America Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 192: Latin America 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 193: Latin America Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 194: Latin America Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 195: Latin America 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
TABLE 196: Latin America Recent Past, Current & Future Analysis for Respiratory Inhalers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 197: Latin America Historic Review for Respiratory Inhalers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 198: Latin America 15-Year Perspective for Respiratory Inhalers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
ARGENTINA
TABLE 199: Argentina Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 200: Argentina Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 201: Argentina 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 202: Argentina Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 203: Argentina Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 204: Argentina 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 205: Argentina Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 206: Argentina Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 207: Argentina 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
BRAZIL
TABLE 208: Brazil Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 209: Brazil Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 210: Brazil 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 211: Brazil Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 212: Brazil Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 213: Brazil 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 214: Brazil Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 215: Brazil Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 216: Brazil 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
MEXICO
TABLE 217: Mexico Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 218: Mexico Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 219: Mexico 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 220: Mexico Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 221: Mexico Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 222: Mexico 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 223: Mexico Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 224: Mexico Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 225: Mexico 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
REST OF LATIN AMERICA
TABLE 226: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 227: Rest of Latin America Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 228: Rest of Latin America 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 229: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 230: Rest of Latin America Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 231: Rest of Latin America 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 232: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 233: Rest of Latin America Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 234: Rest of Latin America 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
MIDDLE EAST
Respiratory Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
TABLE 235: Middle East Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 236: Middle East Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 237: Middle East 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 238: Middle East Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 239: Middle East Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 240: Middle East 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 241: Middle East Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 242: Middle East Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 243: Middle East 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
TABLE 244: Middle East Recent Past, Current & Future Analysis for Respiratory Inhalers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 245: Middle East Historic Review for Respiratory Inhalers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 246: Middle East 15-Year Perspective for Respiratory Inhalers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027
IRAN
TABLE 247: Iran Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 248: Iran Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 249: Iran 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 250: Iran Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 251: Iran Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 252: Iran 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 253: Iran Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 254: Iran Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 255: Iran 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
ISRAEL
TABLE 256: Israel Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 257: Israel Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 258: Israel 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 259: Israel Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 260: Israel Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 261: Israel 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 262: Israel Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 263: Israel Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 264: Israel 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
SAUDI ARABIA
TABLE 265: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 266: Saudi Arabia Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 267: Saudi Arabia 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 268: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 269: Saudi Arabia Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 270: Saudi Arabia 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 271: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 272: Saudi Arabia Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 273: Saudi Arabia 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
UNITED ARAB EMIRATES
TABLE 274: UAE Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 275: UAE Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 276: UAE 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 277: UAE Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 278: UAE Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 279: UAE 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 280: UAE Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 281: UAE Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 282: UAE 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
REST OF MIDDLE EAST
TABLE 283: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 284: Rest of Middle East Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 285: Rest of Middle East 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 286: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 287: Rest of Middle East Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 288: Rest of Middle East 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 289: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 290: Rest of Middle East Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 291: Rest of Middle East 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
AFRICA
Respiratory Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
TABLE 292: Africa Recent Past, Current & Future Analysis for Respiratory Inhalers by Technology - Manual and Digital - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 293: Africa Historic Review for Respiratory Inhalers by Technology - Manual and Digital Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 294: Africa 15-Year Perspective for Respiratory Inhalers by Technology - Percentage Breakdown of Value Sales for Manual and Digital for the Years 2012, 2021 & 2027
TABLE 295: Africa Recent Past, Current & Future Analysis for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 296: Africa Historic Review for Respiratory Inhalers by Product - Metered Dose, Dry Powder and Nebulizers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 297: Africa 15-Year Perspective for Respiratory Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose, Dry Powder and Nebulizers for the Years 2012, 2021 & 2027
TABLE 298: Africa Recent Past, Current & Future Analysis for Respiratory Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 299: Africa Historic Review for Respiratory Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 300: Africa 15-Year Perspective for Respiratory Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2012, 2021 & 2027
IV. COMPETITION
Total Companies Profiled: 131

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings